Asymptomatic SARS-CoV-2 Infection: What is the next step after lockdown? An important challenge for returning to normality is the prevalence of asymptomatic infection and the question of whether such individuals could sustain community virus transmission. Two...
Why have deaths from COVID-19 plateaued in Europe? Is this due to herd immunity? Transmission of SARS-CoV-2 appears to be in marked decline in many countries in Europe, North America and parts of Asia. This follows unprecedented governmental interventions, which...
Physical distancing, face masks and eye protection, do they prevent person-to-person transmission of SARS-CoV-2 and COVID-19? A review published in The Lancet by Derek Chu and others June 1, 2020. The authors aimed to investigate the effects of physical distance, face...
COVID-19 and Anti-inflammatories Initially, due to a French diplomat, it was suggested that anti-inflammatories such as Ibuprofen or Voltarol should not be taken by those patients who might be at risk of developing COVID-19 or being subject to coronavirus...
Blood Group and Severity of COVID-19 It has been found that having type A blood is linked to a 50% increase in the likelihood that a patient would need oxygen or have to go on a ventilator. This was from a pre-print and not peer reviewed article by Ellinghouse...
COVID-19 Vaccine Development, Where Are We? This is neatly discussed by Nelson Lean and Allison McGeer in a comment article in The Lancet dated May 28, 2020. Clearly, developing a safe and effective COVID-19 vaccine is a global priority. Researchers in China,...
